Dr Wu Yue MBA President/CEO
Co-founder and CEO of Cothera Bioscience
CEO/co-founder, Crown Bioscience, public listed on Taiwan Stock Exchange, in 2017 acquired by Japan-based JSR for US$400M CBO of Starvax Inc., an immuno-oncoligy company developing TLR9 agonist
Pattner, Burrril & Co.
COO, UniMicro, a medical device company
PhD & MBA - UC Berkeley